316800-46-1

Basic information

• Product Name: 2,6-DIBROMOPYRIDINE-4-CARBOXALDEHYDE
• Synonyms: 2,6-DIBROMOPYRIDINE-4-CARBOXALDEHYDE;2,6-dibromo-4-pyridinecarboxaldehyde;2,6-Dibromoisonicotinaldehyde;2,6-dibroMo-3-forMylpyridine-4-carboxylic acid;2,6-dibromopyridine-4-carbaldehyde
• CAS NO: 316800-46-1
• Molecular Formula: C6H3Br2NO
• Molecular Weight: 264.9
• Product Categories: Pyridines
• Mol File: 316800-46-1.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 327.2 ºC at 760 mmHg
• Flash Point: 151.7 ºC
• Appearance: /
• Density: 2.09 g/cm³
• Vapor Pressure: 0.000206mmHg at 25°C
• Refractive Index: 1.654
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -5?+-.0.10(Predicted)
• CAS DataBase Reference: 2,6-DIBROMOPYRIDINE-4-CARBOXALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-DIBROMOPYRIDINE-4-CARBOXALDEHYDE(316800-46-1)
• EPA Substance Registry System: 2,6-DIBROMOPYRIDINE-4-CARBOXALDEHYDE(316800-46-1)

Safety Data

• Hazardous Substances Data: 316800-46-1(Hazardous Substances Data)

Usage

General Description

2,6-Dibromopyridine-4-carboxaldehyde is a chemical compound with the molecular formula C7H4Br2NO. It is a yellow to orange solid and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 2,6-DIBROMOPYRIDINE-4-CARBOXALDEHYDE is known for its strong aromatic odor and is considered to be a hazardous material with potential health risks when inhaled or ingested. It is also considered to be harmful to aquatic life and may cause long-term adverse effects in the environment. 2,6-Dibromopyridine-4-carboxaldehyde should be handled and stored with caution, following all safety guidelines and regulations.

InChI:InChI=1/C6H3Br2NO/c7-5-1-4(3-10)2-6(8)9-5/h1-3H

Upstream product

• 2016-99-1 2,6-dibromoisonicotinic acid 
• 99-11-6 citrazinic acid 
• 90050-70-7 ethyl 2,6-dibromo-pyridine-4-carboxylate 
• 223463-02-3 2,6-dibromo-4-(hydroxymethyl)pyridine 

Downstream Products

• 108295-45-0 4′-formyl-2,2′:6′2″-terpyridine 

Relevant articles and documents

TYK-2 INHIBITOR

Disclosed herein is a compound of Formula (I) for inhibiting TYK2 and treating a disease associated with the undesirable tyk-2 activity (tyk-2 related diseases), a method of using the compounds disclosed herein for treating inflammatory or autoimmune disease, and a pharmaceutical composition comprising the same.

Attachment of a RuII Complex to a Self-Folding Hexaamide Deep Cavitand

We report the design, synthesis and characterization of a new RuII metallocavitand that is catalytically active in alkene epoxidation reactions. The elaboration of the resorcin[4]arene's aromatic cavity produced a self-folding, deep hexaamide cavitand featuring a single diverging terpyridine (tpy) group installed at its upper rim. The construction of the metallocavitand involved the initial chelation of a RuIII chloride complex by the tpy ligand followed by the incorporation of 2-(phenylazo)pyridine (azpy) as an ancillary ligand. The resulting RuII chloro complex was converted into the catalytically active aqua counterpart by a ligand exchange process.